000 01516 a2200445 4500
005 20250516210742.0
264 0 _c20140728
008 201407s 0 0 eng d
022 _a1479-683X
024 7 _a10.1530/EJE-13-1013
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWebb, Susan M
245 0 0 _aTreatment effectiveness of pasireotide on health-related quality of life in patients with Cushing's disease.
_h[electronic resource]
260 _bEuropean journal of endocrinology
_cJul 2014
300 _a89-98 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aPituitary ACTH Hypersecretion
_xdrug therapy
650 0 4 _aQuality of Life
650 0 4 _aSomatostatin
_xanalogs & derivatives
650 0 4 _aTreatment Outcome
700 1 _aWare, John E
700 1 _aForsythe, Anna
700 1 _aYang, Min
700 1 _aBadia, Xavier
700 1 _aNelson, Lauren M
700 1 _aSignorovitch, James E
700 1 _aMcLeod, Lori
700 1 _aMaldonado, Mario
700 1 _aZgliczynski, Wojciech
700 1 _ade Block, Christophe
700 1 _aPortocarrero-Ortiz, Lesly
700 1 _aGadelha, Monica
773 0 _tEuropean journal of endocrinology
_gvol. 171
_gno. 1
_gp. 89-98
856 4 0 _uhttps://doi.org/10.1530/EJE-13-1013
_zAvailable from publisher's website
999 _c23763943
_d23763943